Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality

Christina Mayerhofer, David T. Scadden

Open source

DOI
10.1016/j.cmet.2026.08.017
Published
2026-11
Container
Cell Metabolism
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmet.2026.08.017,
  title = {Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality},
  author = {Christina Mayerhofer and David T. Scadden},
  year = {2026},
  journal = {Cell Metabolism},
  doi = {10.1016/j.cmet.2026.08.017},
  url = {https://doi.org/10.1016/j.cmet.2026.08.017}
}

RIS

TY  - JOUR
TI  - Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality
AU  - Christina Mayerhofer
AU  - David T. Scadden
PY  - 2026
JO  - Cell Metabolism
DO  - 10.1016/j.cmet.2026.08.017
UR  - https://doi.org/10.1016/j.cmet.2026.08.017
ER  - 

APA

Mayerhofer, C., & Scadden, D. T. (2026). Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality. Cell Metabolism. https://doi.org/10.1016/j.cmet.2026.08.017

Source records